2026-10-19T01:05:07Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/requestoai:ebyu-rdlopen.rawdatalibrary.net:ebyu/124212026-10-18T21:13:28Zopenairedrivercom_ebyu_10000col_ebyu_10001Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobilityTaşkesen, FatihCezairli, BurakarthrocentesisProlotherapytemporomandibular jointGlucoseHumansInjections, Intra-ArticularPainRange of Motion, ArticularTemporomandibular Joint DisordersTreatment Outcomehumanintraarticular drug administrationrange of motiontemporomandibular joint disorderObjective: The aim of this study was to compare the efficacy of dextrose prolotherapy in conjunction with arthrocentesis and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. Methods: Twenty-four patients suffering from TMJ symptomatic hypermobility received 10% dextrose injections for three sessions at four-week intervals. Twelve patients (P group) received prolotherapy alone; the other 12 (PA group) also underwent a single arthrocentesis session. Patients were evaluated for maximal incisal opening, maximal incisal opening without pain, pain at rest, pain during chewing function, TMJ sound, and locking episode frequency. Results: Pain scores were significantly reduced in both groups, and the locking episode frequency was decreased to a greater extent in the PA than the P group, at both the short and long terms. Conclusion: Prolotherapy is effective in the management of TMJ hypermobility. However, prolotherapy with arthrocentesis may be superior to prolotherapy alone in the management of TMJ hypermobility. © 2020 Taylor & Francis Group, LLC.Taylor and Francis Ltd.2023Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/12421https://doi.org/10.1080/08869634.2020.18618870886-9634enCranio - Journal of Craniomandibular and Sleep Practiceinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12421